
The prescription drug supply chain, including #PBMs, is now making more money off of those #medicines than the #biopharma companies that developed them. thinkbrg.com/insights/public… @txhbi From: Berkeley Research Group #BRG

WWFHTX is a grassroots initiative that unites health consumers, biopharmaceutical company employees vendors, suppliers, academic and community partners.

The prescription drug supply chain, including #PBMs, is now making more money off of those #medicines than the #biopharma companies that developed them. thinkbrg.com/insights/public… @txhbi From: Berkeley Research Group #BRG

Post election there’s bipartisan support to break up the “Big 3” #HealthInsurance - #PBM behemoths that control 80%+ of U.S. prescriptions. forbes.com/sites/joshuacohen…

Average mo. #healthinsurance premium costs almost as much as monthly mortgage payment. But premiums are only part of the story. More from @IWCoalition. @TXDisabilities realclearhealth.com/articles…

.@USDOL rule to require #PBMs to disclose information about their fees & compensation from drugmakers, pharmacies, consultants and more – which could help reveal potential conflicts of interest. @txhbi thehill.com/policy/healthcar…

Why @ProtecTaxpayers says a heavy-handed push by @USTreasury directly undermines #biopharmaceutical innovation to the detriment of millions of patients. protectingtaxpayers.org/pres…

Independent oncology practices bring firsthand perspective on how #PBMs’ control of #cancer medications affects #PatientAccess and care. einpresswire.com/article/952…

Report reveals how private #healthinsurance companies are shortchanging rural hospitals, even as UnitedHealth Group earned enough in just 3 months to keep every at-risk hospital open for a year. @StopAfib healthcareuncovered.substack…

Federal regulators are stepping in with aggressive rate cuts to overhaul the #340B program's financial mechanics. @BioNorthTX healthleadersmedia.com/reven…


New @USDOL regulation will force middlemen #PBMs to reveal their many sources of revenue and the tactics used to gain that revenue. @IAFAccess finance.yahoo.com/healthcare…

Some 70% of Americans support antitrust enforcement to break up large #healthinsurance companies. By a 20-to-1 margin, voters want to block insurers from buying #healthcare providers. elgincourier.com/article/499…

Per @sallypipes, broad restrictions like #COINSAct could give China #biotech firms an advantage while denying U.S. patients access to new treatments. pacificresearch.org/pri-warn…

New report calls for stronger #HealthInsurance accountability by, among other things, stopping AI from making #healthcare altering decisions. @TXDisabilities healthcareuncovered.substack…

.@ambiosecurity paper warns sweeping restrictions on investment, partnerships & supply chains intended to slow China’s rise could undermine America’s own #biotech capacity & national security. @txhbi americanbiosecurity.org/poli…

Mark Cuban’s 5-step plan to make #healthcare more affordable includes #PBMReform and #HealthInsurance reform. #PBMs @ProtecTaxpayers fortune.com/2026/10/21/mark-…

“Due to Congress’ lack of clear expectations and guidelines, the #340B program has become an opaque revenue stream for hospitals and pharmacies, with little accountability to ensure savings benefit patients and taxpayers.” @TCCRI tinyurl.com/4j4jxfws